BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/21/2020 1:23:48 PM | Browse: 1127 | Download: 2799
 |
Received |
|
2020-03-17 12:07 |
|
Peer-Review Started |
|
2020-03-17 12:07 |
|
First Decision by Editorial Office Director |
|
2020-04-25 05:41 |
|
Return for Revision |
|
2020-04-25 05:41 |
|
Revised |
|
2020-05-06 14:30 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-06-29 10:10 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-06-29 22:31 |
|
Articles in Press |
|
2020-06-29 22:31 |
|
Edit the Manuscript by Language Editor |
|
2020-07-03 02:21 |
|
Typeset the Manuscript |
|
2020-07-20 06:59 |
|
Publish the Manuscript Online |
|
2020-07-21 13:23 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Na-Ling Kang, Jie-Min Zhang, Meng-Xin Lin, Xu-Dong Chen, Zu-Xiong Huang, Yue-Yong Zhu, Yu-Rui Liu and Da-Wu Zeng |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Science and Technology Department of Fujian Province |
2018J01164 |
| Quanzhou Science and Technology Bureau Planning Project |
2019N019S |
|
| Corresponding Author |
Da-Wu Zeng, MD, PhD, Associate Chief Physician, Doctor, Doctor, Liver Center, The First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou 350005, Fujian Province, China. zengdw1980@fjmu.edu.cn |
| Key Words |
Ceruloplasmin; Liver fibrosis; Chronic hepatitis B infection; Serum alanine aminotransferase; Noninvasive model; Receiver-operating characteristic |
| Core Tip |
Chronic hepatitis B virus (HBV)-infected individuals with persistently normal serum alanine aminotransferase levels (PNALT) may develop severe liver fibrosis, which requires antiviral therapy. Following up on our previous findings, this multicenter, cross-sectional study showed that ceruloplasmin (CP) has an inverse correlation with liver fibrosis and is a promising predictive marker for liver fibrosis among HBV-infected individuals with PNALT. We developed a noninvasive model using CP, platelet, and HBsAg levels to identify the various stages of fibrosis among HBV-infected individuals with PNALT. Our model could reduce the need for liver biopsy before antiviral treatment. |
| Publish Date |
2020-07-21 13:23 |
| Citation |
Kang NL, Zhang JM, Lin MX, Chen XD, Huang ZX, Zhu YY, Liu YR, Zeng DW. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World J Gastroenterol 2020; 26(27): 3952-3962 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i27/3952.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i27.3952 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
